Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kian Behbakht

Concepts (457)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
48
2025
596
5.440
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
11
2025
134
1.570
 Why?
Endometrial Neoplasms
11
2025
205
1.130
 Why?
Peritoneal Neoplasms
7
2024
104
1.020
 Why?
Drug Resistance, Neoplasm
17
2024
883
1.010
 Why?
Cystadenocarcinoma, Serous
7
2025
89
0.980
 Why?
Genital Neoplasms, Female
6
2020
99
0.840
 Why?
Uterine Cervical Neoplasms
8
2017
268
0.830
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2020
1969
0.820
 Why?
Claudin-4
5
2025
18
0.750
 Why?
Biomarkers, Tumor
9
2025
1329
0.690
 Why?
Hysterectomy
4
2018
138
0.690
 Why?
Antineoplastic Agents
10
2023
2219
0.680
 Why?
Neoplasm Recurrence, Local
8
2025
1150
0.670
 Why?
Fallopian Tube Neoplasms
6
2024
19
0.670
 Why?
TNF-Related Apoptosis-Inducing Ligand
5
2017
54
0.610
 Why?
Gelatin
2
2016
56
0.560
 Why?
Neoplasms, Glandular and Epithelial
3
2015
52
0.540
 Why?
Models, Economic
1
2018
62
0.540
 Why?
Thrombin
2
2016
172
0.530
 Why?
Cell Line, Tumor
22
2025
3551
0.520
 Why?
Hyperthermia, Induced
1
2018
120
0.510
 Why?
Histone-Lysine N-Methyltransferase
3
2024
141
0.500
 Why?
Female
89
2025
79045
0.490
 Why?
Pelvic Infection
1
2016
6
0.480
 Why?
Tissue Adhesives
1
2016
21
0.470
 Why?
Homeodomain Proteins
3
2012
523
0.470
 Why?
Neoplastic Cells, Circulating
2
2017
81
0.440
 Why?
Cost-Benefit Analysis
1
2018
644
0.440
 Why?
Women
1
2015
47
0.430
 Why?
Genomic Instability
2
2025
68
0.420
 Why?
Sirolimus
2
2016
282
0.400
 Why?
Vagina
6
2016
203
0.380
 Why?
Humans
93
2025
145783
0.360
 Why?
Antibodies, Neoplasm
1
2012
34
0.360
 Why?
Middle Aged
50
2025
36309
0.350
 Why?
Health Knowledge, Attitudes, Practice
2
2015
1420
0.350
 Why?
Neoplasm Staging
15
2024
1475
0.340
 Why?
Cisplatin
2
2015
345
0.340
 Why?
Aged
38
2025
26217
0.320
 Why?
Aged, 80 and over
19
2025
8347
0.310
 Why?
Tumor Microenvironment
3
2025
735
0.310
 Why?
Apoptosis
8
2019
2444
0.310
 Why?
Pelvic Exenteration
1
2009
12
0.300
 Why?
Uterine Neoplasms
4
2019
98
0.300
 Why?
Leiomyosarcoma
3
2020
29
0.300
 Why?
Neoadjuvant Therapy
4
2020
467
0.290
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
3
2017
31
0.290
 Why?
Paclitaxel
3
2019
259
0.290
 Why?
Cytoreduction Surgical Procedures
2
2020
69
0.290
 Why?
Phthalazines
2
2019
63
0.290
 Why?
Robotic Surgical Procedures
3
2016
185
0.280
 Why?
Pyrimidines
3
2019
530
0.280
 Why?
Carcinoma, Endometrioid
3
2019
49
0.270
 Why?
Health Personnel
1
2015
757
0.270
 Why?
Carbazoles
1
2008
53
0.270
 Why?
Chemotherapy, Adjuvant
2
2020
427
0.270
 Why?
Gene Expression Regulation, Neoplastic
8
2025
1450
0.270
 Why?
Caffeine
1
2008
74
0.270
 Why?
Azepines
2
2019
105
0.260
 Why?
Papanicolaou Test
2
2004
35
0.260
 Why?
Vaginal Smears
2
2004
54
0.260
 Why?
Protein Kinase C
1
2008
251
0.250
 Why?
Piperazines
2
2019
375
0.250
 Why?
Adult
32
2025
40881
0.250
 Why?
Clinical Competence
1
2015
1247
0.240
 Why?
Postoperative Complications
6
2020
2977
0.230
 Why?
Hemostasis, Surgical
2
2016
25
0.220
 Why?
Tumor Escape
1
2025
49
0.220
 Why?
Immune Evasion
1
2025
61
0.220
 Why?
Laparotomy
2
2015
113
0.210
 Why?
Urban Health
1
2004
96
0.210
 Why?
Adenocarcinoma
4
2015
926
0.210
 Why?
Disease-Free Survival
7
2017
770
0.210
 Why?
Fallopian Tubes
1
2024
33
0.200
 Why?
Histocompatibility Antigens
2
2024
102
0.200
 Why?
Indoles
2
2025
507
0.200
 Why?
Genetic Therapy
2
2014
316
0.190
 Why?
Prognosis
9
2024
4330
0.190
 Why?
Uterine Cervical Dysplasia
2
2003
27
0.190
 Why?
Pyrazoles
2
2020
517
0.190
 Why?
Adenocarcinoma, Clear Cell
2
2021
14
0.180
 Why?
Lipids
2
2025
707
0.180
 Why?
Neoplasm Grading
5
2024
311
0.180
 Why?
Leiomyoma
2
2019
61
0.180
 Why?
Radiosurgery
1
2025
399
0.170
 Why?
Hospitals, Public
1
2001
30
0.170
 Why?
Piperidines
2
2019
222
0.160
 Why?
BRCA2 Protein
3
2019
68
0.160
 Why?
Hospitals, University
1
2001
176
0.160
 Why?
Vulvar Neoplasms
1
2020
13
0.160
 Why?
Cervix Uteri
3
2011
50
0.160
 Why?
Healthcare Disparities
2
2018
736
0.160
 Why?
Epoxy Compounds
1
2020
31
0.160
 Why?
Early Detection of Cancer
1
2025
486
0.160
 Why?
Mutation
5
2019
4090
0.150
 Why?
Carnitine O-Palmitoyltransferase
1
2020
49
0.150
 Why?
Rad51 Recombinase
1
2019
15
0.150
 Why?
Treatment Outcome
11
2020
11794
0.150
 Why?
Cell Movement
2
2016
963
0.150
 Why?
Up-Regulation
2
2020
848
0.150
 Why?
Vaccines, Conjugate
1
2019
59
0.150
 Why?
Machine Learning
1
2025
587
0.150
 Why?
Enoxaparin
1
2020
68
0.150
 Why?
Receptors, Adiponectin
1
2019
22
0.150
 Why?
Poly(ADP-ribose) Polymerases
1
2019
88
0.140
 Why?
Interleukin-12
2
2014
115
0.140
 Why?
Animals
15
2025
38101
0.140
 Why?
Sequence Analysis, RNA
2
2019
442
0.140
 Why?
Neoplasms
4
2017
2913
0.140
 Why?
CD8-Positive T-Lymphocytes
1
2024
923
0.140
 Why?
Pyridones
1
2020
209
0.140
 Why?
Lymph Node Excision
2
2020
173
0.140
 Why?
Mice
11
2025
18355
0.140
 Why?
Cancer Vaccines
1
2019
163
0.140
 Why?
Adjuvants, Immunologic
1
2019
244
0.130
 Why?
Cost Savings
1
2018
86
0.130
 Why?
Ovariectomy
2
2015
166
0.130
 Why?
Cell Growth Processes
2
2008
48
0.130
 Why?
Oncologists
1
2018
47
0.130
 Why?
Patient Acceptance of Health Care
1
2004
883
0.130
 Why?
Dose-Response Relationship, Drug
4
2008
2028
0.130
 Why?
Sarcoma
1
2020
207
0.130
 Why?
Antineoplastic Agents, Phytogenic
1
2019
178
0.130
 Why?
Aurora Kinase A
1
2017
61
0.130
 Why?
Leukocyte Common Antigens
1
2017
87
0.130
 Why?
Pregnancy Complications, Infectious
1
2002
440
0.130
 Why?
Anion Transport Proteins
1
2017
8
0.130
 Why?
Breast Neoplasms
4
2019
2393
0.120
 Why?
Salpingectomy
2
2015
15
0.120
 Why?
Sexual Dysfunctions, Psychological
1
2017
30
0.120
 Why?
Curettage
1
2016
8
0.120
 Why?
beta Catenin
1
2019
254
0.120
 Why?
Gestational Trophoblastic Disease
1
2016
6
0.120
 Why?
Fatty Acids
1
2020
457
0.120
 Why?
Keratins
1
2017
171
0.120
 Why?
Survival Rate
5
2020
2094
0.120
 Why?
Megestrol Acetate
1
2016
3
0.120
 Why?
Carcinoma, Neuroendocrine
1
2016
37
0.120
 Why?
Minority Groups
1
2018
285
0.120
 Why?
Colony Count, Microbial
1
2016
89
0.120
 Why?
Neoplasms, Squamous Cell
1
1996
4
0.120
 Why?
Sexual Dysfunction, Physiological
1
2017
75
0.120
 Why?
Standard of Care
1
2016
81
0.120
 Why?
Gynecology
1
2018
181
0.120
 Why?
Medroxyprogesterone Acetate
1
2015
33
0.120
 Why?
Adenoviridae
1
1996
199
0.120
 Why?
Risk Factors
6
2016
10919
0.120
 Why?
Venous Thromboembolism
1
2020
328
0.110
 Why?
Cell Survival
4
2025
1104
0.110
 Why?
Keratin-5
1
2015
44
0.110
 Why?
Gene Expression Profiling
2
2019
1777
0.110
 Why?
Brachytherapy
1
2016
132
0.110
 Why?
Molecular Targeted Therapy
1
2018
441
0.110
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2017
979
0.110
 Why?
Tamoxifen
1
2016
193
0.110
 Why?
Tretinoin
1
1996
125
0.110
 Why?
Immunohistochemistry
3
2016
1723
0.110
 Why?
Chemoradiotherapy
1
2016
239
0.110
 Why?
Cell Proliferation
5
2024
2514
0.110
 Why?
Combined Modality Therapy
4
2020
1271
0.110
 Why?
Anticoagulants
1
2020
748
0.110
 Why?
CA-125 Antigen
2
2008
13
0.110
 Why?
Abdominal Abscess
1
2014
26
0.110
 Why?
Antineoplastic Agents, Hormonal
1
2015
196
0.100
 Why?
Mice, SCID
2
2012
369
0.100
 Why?
Xenograft Model Antitumor Assays
3
2024
936
0.100
 Why?
Cytokines
1
2002
2069
0.100
 Why?
Glycoproteins
1
2015
354
0.100
 Why?
Kaplan-Meier Estimate
4
2020
971
0.100
 Why?
Endometrium
1
2014
64
0.100
 Why?
Surgeons
1
2018
340
0.100
 Why?
Interpersonal Relations
1
2017
400
0.100
 Why?
Lipid Metabolism
1
2017
529
0.100
 Why?
Cell Cycle
2
2025
598
0.100
 Why?
Case-Control Studies
5
2025
3634
0.100
 Why?
Immunotherapy
1
2018
668
0.100
 Why?
Quality of Health Care
1
2018
693
0.100
 Why?
Double-Blind Method
4
2025
2064
0.100
 Why?
Transforming Growth Factor beta
1
1996
474
0.100
 Why?
Reoperation
1
2016
637
0.100
 Why?
Proto-Oncogene Proteins c-akt
2
2016
440
0.100
 Why?
Pelvic Neoplasms
1
2013
24
0.100
 Why?
Models, Biological
3
2019
1764
0.100
 Why?
Genes, Tumor Suppressor
3
1998
85
0.090
 Why?
Plasmids
1
2014
373
0.090
 Why?
Antigens, CD
1
2015
558
0.090
 Why?
Young Adult
5
2020
14254
0.090
 Why?
Gardnerella vaginalis
2
2002
3
0.090
 Why?
Cell Division
2
2008
757
0.090
 Why?
Antibody Specificity
1
2012
179
0.090
 Why?
Escherichia coli
1
2016
835
0.090
 Why?
Neoplastic Stem Cells
1
2015
409
0.090
 Why?
Endocrine Gland Neoplasms
1
2011
1
0.090
 Why?
RNA, Messenger
2
2012
2805
0.090
 Why?
Transplantation, Heterologous
1
2012
170
0.090
 Why?
RNA, Small Interfering
3
2020
638
0.080
 Why?
Cyclin D1
1
2011
64
0.080
 Why?
Drug Synergism
2
2011
354
0.080
 Why?
Proteasome Inhibitors
1
2011
41
0.080
 Why?
MicroRNAs
1
2017
686
0.080
 Why?
DNA
1
2017
1437
0.080
 Why?
Adenocarcinoma, Mucinous
1
2011
76
0.080
 Why?
Transfection
2
2007
927
0.080
 Why?
Cadherins
1
2011
201
0.080
 Why?
Peptides
1
2015
999
0.080
 Why?
Neoplasm Invasiveness
3
2016
508
0.080
 Why?
Age Factors
5
2016
3346
0.070
 Why?
Lymphoma
1
2011
241
0.070
 Why?
Inflammation
1
2020
2884
0.070
 Why?
Skin Transplantation
1
2009
85
0.070
 Why?
Anastomosis, Surgical
1
2009
162
0.070
 Why?
Urokinase-Type Plasminogen Activator
1
2008
25
0.070
 Why?
Papillomaviridae
2
2002
116
0.070
 Why?
Adaptor Proteins, Signal Transducing
1
2011
426
0.070
 Why?
G2 Phase
1
2008
39
0.070
 Why?
Radiation-Protective Agents
1
2008
17
0.070
 Why?
Adolescent
5
2020
22577
0.070
 Why?
Rectum
1
2009
182
0.070
 Why?
TOR Serine-Threonine Kinases
1
2011
456
0.070
 Why?
Heterografts
2
2019
143
0.060
 Why?
Genes, BRCA1
2
1998
45
0.060
 Why?
Models, Statistical
1
2011
672
0.060
 Why?
Microsatellite Instability
2
2019
55
0.060
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2019
108
0.060
 Why?
Urinary Bladder
1
2009
196
0.060
 Why?
Cell Culture Techniques
2
2020
375
0.060
 Why?
Tumor Suppressor Protein p53
3
2019
534
0.060
 Why?
Cysteine
1
2008
211
0.060
 Why?
PTEN Phosphohydrolase
2
2019
165
0.060
 Why?
Gynecologic Surgical Procedures
2
2020
67
0.060
 Why?
Models, Animal
1
2008
392
0.060
 Why?
Adenosarcoma
2
2005
2
0.060
 Why?
Proportional Hazards Models
3
2020
1330
0.060
 Why?
Polymerase Chain Reaction
4
2002
1043
0.060
 Why?
Follow-Up Studies
4
2020
5428
0.060
 Why?
Signal Transduction
4
2012
5224
0.060
 Why?
Indazoles
2
2019
85
0.060
 Why?
Colposcopy
2
2003
18
0.060
 Why?
Maintenance Chemotherapy
1
2025
42
0.060
 Why?
Intestinal Neoplasms
1
2005
30
0.060
 Why?
Cell Count
2
2015
319
0.060
 Why?
Neoplasm Proteins
3
1998
442
0.060
 Why?
Ovary
1
2007
234
0.060
 Why?
Length of Stay
3
2015
1350
0.050
 Why?
Sexual Behavior
1
2009
495
0.050
 Why?
Retrospective Studies
6
2020
17330
0.050
 Why?
Ultraviolet Rays
1
2008
385
0.050
 Why?
Germ-Line Mutation
2
1996
177
0.050
 Why?
Chicago
1
2004
62
0.050
 Why?
Tumor Cells, Cultured
2
1996
887
0.050
 Why?
Peptide Fragments
1
2008
697
0.050
 Why?
Disease Progression
3
2019
2865
0.050
 Why?
United States
5
2022
16126
0.050
 Why?
Antioxidants
1
2008
550
0.050
 Why?
Transcription Factors
4
2011
1736
0.050
 Why?
Blood Loss, Surgical
2
2015
114
0.050
 Why?
Survival Analysis
4
2020
1378
0.050
 Why?
Activating Transcription Factor 6
1
2023
19
0.050
 Why?
Receptors, Estrogen
2
2015
404
0.050
 Why?
Transcription Factor AP-1
1
2023
79
0.050
 Why?
X-ray Repair Cross Complementing Protein 1
1
2022
14
0.050
 Why?
Women's Health
1
2004
316
0.050
 Why?
Neoplasm Metastasis
2
2015
688
0.040
 Why?
Gene Expression
1
2007
1478
0.040
 Why?
Trichomonas vaginalis
1
2002
11
0.040
 Why?
Vaginal Neoplasms
1
2001
19
0.040
 Why?
Yeasts
1
2002
52
0.040
 Why?
Phosphatidylinositol 3-Kinases
2
2016
383
0.040
 Why?
Vaginosis, Bacterial
1
2001
10
0.040
 Why?
Vaginal Diseases
1
2001
19
0.040
 Why?
Cell Nucleus
1
2025
588
0.040
 Why?
Risk Assessment
3
2016
3752
0.040
 Why?
Medical Oncology
1
2024
340
0.040
 Why?
Endometriosis
1
2001
58
0.040
 Why?
DNA, Neoplasm
2
1998
160
0.040
 Why?
DNA Primers
1
2002
505
0.040
 Why?
Vulvectomy
1
2020
2
0.040
 Why?
Dermatofibrosarcoma
1
2020
7
0.040
 Why?
Pregnancy
3
2016
7216
0.040
 Why?
Histiocytoma, Malignant Fibrous
1
2020
6
0.040
 Why?
Epithelial Cells
1
2007
1134
0.040
 Why?
Quality of Life
2
2025
3211
0.040
 Why?
Hospitals, Urban
1
2001
142
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
Medically Uninsured
1
2001
132
0.040
 Why?
Liposarcoma
1
2020
31
0.040
 Why?
Databases, Factual
2
2016
1491
0.040
 Why?
Alleles
3
2017
896
0.040
 Why?
Disease Models, Animal
2
2024
4568
0.040
 Why?
Anoikis
1
2020
31
0.040
 Why?
Interleukin-10
1
2002
311
0.040
 Why?
Hemocyanins
1
2019
61
0.040
 Why?
Rhabdomyosarcoma
1
2020
65
0.040
 Why?
Chitinase-3-Like Protein 1
1
2019
18
0.040
 Why?
DNA Repair
1
2022
255
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2002
849
0.040
 Why?
Diagnosis, Differential
2
2019
1512
0.040
 Why?
Prospective Studies
4
2016
8078
0.040
 Why?
Logistic Models
1
2004
2139
0.040
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2019
27
0.040
 Why?
Radiotherapy
1
2020
206
0.040
 Why?
SEER Program
1
2020
230
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
65
0.040
 Why?
Poly-ADP-Ribose Binding Proteins
1
2019
33
0.040
 Why?
DNA Polymerase II
1
2019
35
0.040
 Why?
Lymphatic Metastasis
1
2020
336
0.040
 Why?
Gene Knockdown Techniques
1
2020
334
0.040
 Why?
DNA Damage
1
2022
437
0.040
 Why?
Chromosomes, Human, Pair 7
1
1998
17
0.040
 Why?
Cell Cycle Checkpoints
1
2019
97
0.040
 Why?
Cytoskeletal Proteins
1
2019
157
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
138
0.030
 Why?
Mitosis
1
2019
193
0.030
 Why?
Microtubule-Associated Proteins
1
2019
194
0.030
 Why?
Interleukin-1
1
2002
961
0.030
 Why?
AMP-Activated Protein Kinases
1
2019
192
0.030
 Why?
Europe
1
2019
421
0.030
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
1998
41
0.030
 Why?
Interleukin-6
1
2002
780
0.030
 Why?
Image Cytometry
1
2017
11
0.030
 Why?
Wnt Signaling Pathway
1
2019
212
0.030
 Why?
Chromosomes, Human, Pair 14
1
1997
23
0.030
 Why?
Ganciclovir
1
1996
53
0.030
 Why?
Chromosome Deletion
1
1997
126
0.030
 Why?
Hospitals, Private
1
2016
12
0.030
 Why?
Health Facility Size
1
2016
13
0.030
 Why?
Socioeconomic Factors
1
2001
1327
0.030
 Why?
Mass Spectrometry
1
2019
732
0.030
 Why?
Chorionic Gonadotropin
1
2016
78
0.030
 Why?
Cell Separation
1
2017
306
0.030
 Why?
Oxidation-Reduction
1
2020
1069
0.030
 Why?
Ifosfamide
1
1996
39
0.030
 Why?
AC133 Antigen
1
2015
20
0.030
 Why?
Cell Line, Transformed
1
1996
138
0.030
 Why?
Cell Differentiation
2
2011
2050
0.030
 Why?
Time Factors
2
2019
7134
0.030
 Why?
Tissue Array Analysis
1
2015
49
0.030
 Why?
Hospital Charges
1
1996
46
0.030
 Why?
Hospitals, Teaching
1
2016
121
0.030
 Why?
Marriage
1
2017
123
0.030
 Why?
Caspase 3
1
2016
242
0.030
 Why?
Cystadenocarcinoma, Papillary
1
1995
4
0.030
 Why?
Antigens, Neoplasm
1
2017
271
0.030
 Why?
Carboplatin
1
1996
164
0.030
 Why?
RNA-Binding Proteins
1
2019
447
0.030
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2015
69
0.030
 Why?
Tumor Burden
1
2016
325
0.030
 Why?
Ileus
1
2015
13
0.030
 Why?
DNA Mismatch Repair
1
2015
53
0.030
 Why?
Genes, p53
1
1995
67
0.030
 Why?
Cell Cycle Proteins
1
2019
630
0.030
 Why?
Disease Management
1
2019
653
0.030
 Why?
Urinary Retention
1
2015
24
0.030
 Why?
Income
1
2016
203
0.030
 Why?
Female Urogenital Diseases
1
2014
7
0.030
 Why?
RNA Interference
1
2016
475
0.030
 Why?
Taxoids
1
2015
114
0.030
 Why?
Multivariate Analysis
2
1996
1547
0.030
 Why?
Morbidity
1
2015
322
0.030
 Why?
Receptors, Androgen
1
2015
149
0.030
 Why?
Elective Surgical Procedures
1
2016
203
0.030
 Why?
Drug Administration Schedule
1
2016
782
0.030
 Why?
Reference Values
1
1996
798
0.030
 Why?
Blood Volume
1
2014
65
0.030
 Why?
Sensitivity and Specificity
1
2019
2000
0.030
 Why?
Intraoperative Complications
1
2015
157
0.030
 Why?
Bevacizumab
1
2015
168
0.030
 Why?
Point Mutation
1
1995
241
0.030
 Why?
Infusions, Parenteral
1
2014
48
0.030
 Why?
Polyethyleneimine
1
2014
19
0.030
 Why?
Bleomycin
1
1996
255
0.030
 Why?
Receptors, Progesterone
1
2015
244
0.030
 Why?
Histones
1
2019
666
0.030
 Why?
DNA, Viral
1
1996
356
0.030
 Why?
Pelvis
1
2015
125
0.020
 Why?
Hemostatics
1
2014
64
0.020
 Why?
Tumor Suppressor Proteins
1
2016
322
0.020
 Why?
Deoxycytidine
1
2015
220
0.020
 Why?
Drainage
1
2014
185
0.020
 Why?
Insurance, Health
1
2016
311
0.020
 Why?
Anemia
1
2015
191
0.020
 Why?
Thrombocytopenia
1
2015
204
0.020
 Why?
Urban Population
1
2016
494
0.020
 Why?
Preoperative Care
1
2015
380
0.020
 Why?
Polymorphism, Single-Stranded Conformational
3
1998
26
0.020
 Why?
Gene Transfer Techniques
1
2014
187
0.020
 Why?
Patient Readmission
1
2018
773
0.020
 Why?
Membrane Proteins
1
2019
1166
0.020
 Why?
Ultrasonography
1
2016
788
0.020
 Why?
Linear Models
1
1994
849
0.020
 Why?
Biomarkers
1
2024
4302
0.020
 Why?
Cholesterol
1
2014
408
0.020
 Why?
Referral and Consultation
1
2018
869
0.020
 Why?
Analysis of Variance
1
1994
1300
0.020
 Why?
Zinc Finger E-box-Binding Homeobox 1
1
2011
21
0.020
 Why?
Perioperative Period
1
2011
71
0.020
 Why?
Mutant Proteins
1
2011
105
0.020
 Why?
DNA Fragmentation
1
2011
40
0.020
 Why?
Risk Reduction Behavior
1
2013
217
0.020
 Why?
Comorbidity
1
2016
1662
0.020
 Why?
Rural Population
1
2016
661
0.020
 Why?
Protein Kinase Inhibitors
1
2017
981
0.020
 Why?
Fas Ligand Protein
1
2011
61
0.020
 Why?
Neovascularization, Pathologic
1
2012
287
0.020
 Why?
Hyperplasia
1
2011
177
0.020
 Why?
Neoplasm Transplantation
1
2011
246
0.020
 Why?
Tomography, X-Ray Computed
2
2014
2770
0.020
 Why?
Polymorphism, Single Nucleotide
1
2017
2181
0.020
 Why?
Administration, Oral
1
2012
867
0.020
 Why?
Epithelial-Mesenchymal Transition
1
2011
220
0.020
 Why?
Regression Analysis
1
2011
1001
0.020
 Why?
Polyethylene Glycols
1
2014
649
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2008
15
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2015
992
0.020
 Why?
Pregnancy Complications
1
2014
603
0.020
 Why?
Anti-Bacterial Agents
2
2014
1925
0.020
 Why?
Blotting, Western
1
2011
1184
0.020
 Why?
Placebos
1
2008
193
0.020
 Why?
Injections, Subcutaneous
1
2008
170
0.020
 Why?
Mice, Hairless
1
2008
47
0.020
 Why?
Patient Discharge
1
2015
995
0.020
 Why?
Enzyme Inhibitors
1
2011
821
0.020
 Why?
Sulfonamides
1
2011
583
0.020
 Why?
Molecular Sequence Data
3
1996
2883
0.020
 Why?
Chromosome Mapping
2
1998
507
0.020
 Why?
Quality Improvement
1
2015
1296
0.020
 Why?
Genetic Markers
2
1998
338
0.020
 Why?
Receptors, Cell Surface
1
2008
372
0.010
 Why?
Frameshift Mutation
2
1996
31
0.010
 Why?
Gene Deletion
2
1998
392
0.010
 Why?
Carcinosarcoma
1
2005
23
0.010
 Why?
Cross-Sectional Studies
1
2017
5925
0.010
 Why?
DNA Mutational Analysis
2
1996
410
0.010
 Why?
Cohort Studies
1
2015
6033
0.010
 Why?
Colorado
1
2014
4556
0.010
 Why?
Severity of Illness Index
1
2011
2933
0.010
 Why?
Obesity
1
2016
3118
0.010
 Why?
Base Sequence
2
1996
2171
0.010
 Why?
Electrophoresis, Gel, Pulsed-Field
1
2001
22
0.010
 Why?
Genes, rRNA
1
2001
38
0.010
 Why?
Metronidazole
1
2001
20
0.010
 Why?
DNA, Bacterial
1
2001
320
0.010
 Why?
Microbial Sensitivity Tests
1
2001
365
0.010
 Why?
RNA, Ribosomal, 16S
1
2001
508
0.010
 Why?
Loss of Heterozygosity
1
1998
52
0.010
 Why?
Microsatellite Repeats
1
1998
157
0.010
 Why?
Ecosystem
1
2001
478
0.010
 Why?
Actuarial Analysis
1
1996
16
0.010
 Why?
Genes, Neoplasm
1
1995
26
0.010
 Why?
Sequence Analysis, DNA
1
1998
778
0.010
 Why?
BRCA1 Protein
1
1995
82
0.010
 Why?
Age of Onset
1
1996
557
0.010
 Why?
Introns
1
1995
256
0.010
 Why?
Exons
1
1995
364
0.010
 Why?
Amino Acid Sequence
1
1995
2131
0.010
 Why?
Male
1
2017
73010
0.000
 Why?
Behbakht's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (457) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)